Historical perspective of low- vs. high-dose diuretics

Journal of the American Society of Hypertension

Volumn 1, Issue 6, 2007, Pages 373-380

  Materson, Barry J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

diuretics; hypertension; inulin; Thiazide

Indexed keywords

AMILORIDE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BISOPROLOL; CAPTOPRIL; CHLOROTHIAZIDE; CHLORTALIDONE; CLONIDINE; DIURETIC AGENT; FUROSEMIDE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; METHYLDOPA; METOLAZONE; PLACEBO; POTASSIUM CHLORIDE; PROPRANOLOL; RESERPINE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TORASEMIDE; TRIAMTERENE; VERATRUM ALKALOID;

ANTIHYPERTENSIVE ACTIVITY; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG POTENCY; DRUG POTENTIATION; DRUG SAFETY; GYNECOMASTIA; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOKALEMIA; HYPONATREMIA; INSULIN SENSITIVITY; LOW DRUG DOSE; MONOTHERAPY; NATRIURESIS; OPTIMAL DRUG DOSE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SYSTOLIC HYPERTENSION; THERAPY RESISTANCE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; URIC ACID BLOOD LEVEL; VASODILATATION;

EID: 36549028318     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2007.06.007     Document Type: Review

References (44)

1. Materson B.J., Johnson A.E., and Perez-Stable E.C. Inulin labeled with chromium 51 for determination of glomerular filtration rate. JAMA 207 (1969) 94-96
2. Maher F.T., and Tauxe N. Renal clearance in man of pharmaceuticals containing radioactive iodine. JAMA 207 (1969) 97-104
3. Perez-Stable E.C., and Materson B.J. Diuretic drug therapy of edema. Med Clin North Am 55 (1971) 359-372
4. Materson B.J., Hotchkiss J.L., Barkin J.S., Reitberg B.H., Bailey K., and Perez-Stable E.C. Oral Metolazone: effects on urine composition in water-loaded normal man. Curr Ther Res 14 (1972) 545-560
5. Materson B.J., Oster J.R., and Perez-Stable E.C. Antihypertensive effects of metolazone (Zaroxolyn). Curr Ther Res 16 (1974) 890-896
6. Freis E.D., and Wilson I.M. Potentiating effect of cholorothiazide (Diuril) in combination with antihypertensive agents: preliminary report. Med Ann Dist Columbia 26 (1957) 468 516
7. Freis E.D., Wanko A., Wilson I.M., and Parrish A.E. Treatment of essential hypertension with chlorothiazide (diuril); its use alone and combined with other antihypertensive agents. JAMA 166 (1958) 137-140
8. McMahon F.G. Management of essential hypertension. The new low-dose era. 2nd ed. (1984), Futura, Mount Kisko, New York
9. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: I. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 202 (1967) 1028-1034
10. Propranolol in the treatment of essential hypertension. Veterans Administration Cooperative Study Group on Antihypertensive Agents. JAMA 237 (1977) 2303-2310
11. Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: a cooperative study. JAMA 237 (1977) 255-261
12. The 1980 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 140 (1980) 1280-1285
13. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. I. Results of short-term titration with emphasis on racial differences in response. Veterans Administration Cooperative Study Group on Antihypertensive Agents. JAMA 248 (1982) 1996-2003
14. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. Veterans Administration Cooperative Study Group on Antihypertensive Agents. JAMA 248 (1982) 2004-2011
15. The 1984 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 144 (1984) 1045-1057
16. Cushman W.C., Khatri I., Materson B.J., Reda D.J., Freis E.D., Goldstein G., et al. Treatment of hypertension in the elderly. III. Response of isolated systolic hypertension to various doses of hydrochlorothiazide: results of a Department of Veterans Affairs Cooperative Study. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med 151 (1991) 1954-1960
17. Materson B.J., Reda D.J., Cushman W.C., Massie B.M., Freis E.D., Kochar M.S., et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Engl J Med 328 (1993) 914-921
18. Materson B.J., Reda D.J., and Cushman W.C. Department of veterans Affairs single-drug therapy of hypertension study. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Am J Hypertens 8 (1995) 189-192
19. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., et al., Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
20. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). [Erratum in: JAMA 2003;289:178; JAMA 2004;291:2196]. JAMA 288 (2002) 2981-2997
21. Materson B.J., Reda D.J., Cushman W.C., and Henderson W.G. Results of combination antihypertensive therapy after failure of each of the components. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. J Hum Hypertens 9 (1995) 791-796
22. Cushman W.C., Materson B.J., Williams D.W., and Reda D.J. Pulse pressure changes with six classes of antihypertensive agents in a randomized controlled trial. Hypertension 38 (2001) 953-957
23. Frishman W.H., Bryzinski B.S., Coulson L.R., DeQuattro V.L., Vlachakis N.D., Mroczek W.J., et al. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide. [Erratum in: Arch Intern Med 1995;155:709]. Arch Intern Med 154 (1994) 1461-1468
24. Ames R.P., and Hill P. Elevation of serum lipids during diuretic therapy of hypertension. Am J Med 61 (1976) 748-757
25. Amery A., Berthaux P., Birkenhager W., Boel A., Brixko P., Bulpitt C., et al. Antihypertensive therapy in patient above age 60. Third interim report of the European Working Party on High blood pressure in Elderly (EWPHE). Acta Cardiol 33 (1978) 113-134
26. Ekbom T., Dahlof B., Hansson L., Lindholm L.H., and Wester P.O. Antihypertensive efficacy and side effects of three beta-blockers and a diuretic in elderly hypertensives: a report from the STOP-Hypertension Study. J Hypertens 10 (1992) 1525-1530
27. Dydra I., Dufault C., Hebert J.-G., Tremblay G., and Genest J. Studies on a new diuretic: chlorthalidone. Can Med Assoc J 86 (1962) 475-482
28. Carney S., Gilles A.L., and Morgan T. Optimal dose of a thiazide diuretic. Med J Aust 2 (1976) 692-693
29. Tweeddale M.G., Ogilvie R.I., and Ruedy J. Antihypertensive and biochemical effects of chlorthalidone. Clin Pharmacol Ther 22 (1977) 519-527
30. Materson B.J., Oster J.R., Michael U.F., Bolton S.M., Burton Z.C., Stanbaugh J.E., et al. Dose response to chlorthalidone in patients with mild hypertension. Efficacy of a lower dose. Clin Pharmacol Ther 24 (1978) 192-198
31. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 242 (1979) 2562-2571
32. Neaton J.D., Grimm Jr. R.H., Prineas R.J., Stamler J., Grandits G.A., Elmer P.J., et al., Treatment of Mild Hypertension Study Research Group. JAMA 270 (1993) 718-724
33. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 265 (1991) 3255-3264
34. Ernst M.E., Carter B.L., Goerdt C.J., Steffensmeier J.J., Phillips B.B., Zimmerman M.B., et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 47 (2006) 352-358
35. Sica D.A. Chlorthalidone: has it always been the best thiazide-type diuretic?. Hypertension 47 (2006) 321-322
36. Carter B.L., Ernst M.E., and Cohen J.D. Hydrochlorothiazide vs. chlorthalidone: evidence supporting their interchangeability. Hypertension 43 (2004) 4-9
37. Psaty B.M., Lumley T., and Furberg C.D. Meta-analysis of health outcomes of chlorthalidone-based vs. nonchlorthalidone-based low-dose diuretic therapies. JAMA 292 (2004) 43-44
38. Witchite S., Kamoun A., and Chiche P. A double-blind study in hypertensive patients of an original new compound, indapamide. Curr Med Res Opin 3 (1975) 1-8
39. Anavekar S.N., Ludbrooke A., Louis W.J., and Doyle A.E. Evaluation of indapamide in the treatment of hypertension. J Cardiovasc Pharmacol 1 (1979) 389-394
40. Capone P., Vukovich R.A., Neiss E.S., Bolton S., and Reeves R.L. Multicenter dose-response study of the effect of indapamide in the treatment of patients with mild to moderate hypertension. Clin Ther 5 (1983) 305-316
41. Mallion J.M., Asmar R., Boutelant S., and Guez D. Twenty-four hour antihypertensive efficacy of indapamide, 1.5 mg sustained release: results of two randomized double-blind controlled studies. J Cardiovasc Pharmacol 32 (1998) 673-678
42. Nishizaka M.K., Zaman M.A., and Calhoun D.A. Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens 16 (2003) 925-930
43. Goodfriend T.L. Treating resistant hypertension with a neglected old drug. Hypertension 49 (2007) 763-764
44. Dupont A.G., Schoors D., Six R.O., and Vanhaelst L. Antihypertensive efficacy of low-dose torasemide in essential hypertension: a placebo-controlled study. J Hum Hypertens 2 (1988) 265-268